When you are committed to providing your customers with seamless performance and real diagnostic results, you need a solutions partner who can provide the technologies, services, and insights you need to deliver for in-vitro diagnostics around the world. Our excellent nucleic acid solutions and over 25 years of experience give you the capability to meet your customers’ needs.
You can benefit from several options of our services:
2022
We produce our products in compliance with the applicable regulatory requirements of the new European REGULATION (EU) 2017/746 for in-vitro diagnostic medical devices (IVDR).
2020
Invitek Molecular supports clinicians and test labs with kits for manual and automated Virus RNA isolation in the fight against the COVID-19 pandemic
2019
We became a member of the NUVISAN Group, renaming to Invitek Molecular
Realignment of our business model to providing customized development, contract manufacturing and OEM solutions to the in-vitro diagnostic industry
2018
Product launch of the InviMag® FFPE DNA Kit/ IG for automated DNA extraction from FFPE slides
2016
Product launch of the InviGenius® PLUS incl. extraction kits for liquid biopsy
2014
Product launch of the Universal kit series for DNA/RNA extraction from pathogens and genomic DNA
2010
Product launch of the InviGenius® automation platform
2009
Acquisition by STRATEC SE, renaming to STRATEC Molecular GmbH
2004
InviMag® technology
Invitek magnetic particles for use on automated purification platforms
1998
IP for non-chaotropic chemistry – Invitek core technology
Leveraging this unique and proprietary technology, we have developed several innovative sample preparation and purification solutions like the RTP®, PSP® and MSB® technologies
1992
Invitek Gesellschaft für Biotechnik & Biodesign mbH was founded as one of the first biotech companies in Berlin at the Biomedical Park in Berlin-Buch